VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 17 filers reported holding VASCULAR BIOGENICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spectrum Planning & Advisory Services Inc. | 16,000 | $4,157 | 0.01% |
CATALYST FINANCIAL PARTNERS LLC | 39,000 | $8,970 | 0.00% |
Virtu Financial LLC | 79,892 | $18 | 0.00% |
MORGAN STANLEY | 327,011 | $75,213 | 0.00% |
HBK Sorce Advisory LLC | 20,575 | $4,733 | 0.00% |
Harel Insurance Investments & Financial Services Ltd. | 11,000 | $3 | 0.00% |
HRT FINANCIAL LP | 13,526 | $3 | 0.00% |
Tower Research Capital LLC (TRC) | 937 | $216 | 0.00% |
ROYAL BANK OF CANADA | 798 | $0 | 0.00% |
NewEdge Advisors, LLC | 1,700 | $391 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 100 | $23 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 32,900 | $7,567 | 0.00% |
OSAIC HOLDINGS, INC. | 22,491 | $5,200 | 0.00% |
BANK OF AMERICA CORP /DE/ | 8,192 | $1,884 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 127,293 | $29,277 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 40,323 | $9,274 | 0.00% |
External links
This page lists VASCULAR BIOGENICS LTD's shareholders in Q2 2023. To view VASCULAR BIOGENICS LTD's shareholder history, click here.